For advertising Queries please call 9899152321 or email sales@medicaldarpan.com
For advertising Queries please call 9899152321 or email sales@medicaldarpan.com
For advertising Queries please call 9899152321 or email sales@medicaldarpan.com
For advertising Queries please call 9899152321 or email sales@medicaldarpan.com

Blog

13 Apr, 2021
Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%.

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%. Al...
13 Apr, 2021
Lupin Launches Authorized Generic Version of Alinia

Mumbai, Baltimore, March 10, 2021: Global pharma major, Lupin Limited (Lupin), today announced the launch of the authorized generic version of Alinia...
13 Apr, 2021
Piramal Enterprises Appoints Khushru Jijina to its Board as Executive Director, Financial Services

Mumbai, India | April 2, 2021: We are pleased to share, that Khushru Jijina, Managing Director, Piramal Capital, will join the Board of Piramal Enterp...
13 Apr, 2021
Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs

Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that PPL ...
13 Apr, 2021
Piramal Pharma Solutions Enters Into a Master Services Agreement with Plus Therapeutics, Inc.

Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that the ...
13 Apr, 2021
Dr. Reddy’s launched Sapropterin Dihydrochloride Powder

Hyderabad, India and Princeton, NJ, USA. April 7, 2021 - Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, NSEIFSC: DR REDDY alo...
23 Mar, 2021
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats

March 23, 2021, MUMBAI - Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as "Cipla") and SIGA Technologies,...
19 Mar, 2021
Cipla pledges support to ‘Terra Carta’, for a sustainable future

Mumbai; March 19, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has pledged support to ‘Terra...
18 Mar, 2021
Thermo Fisher Scientific Signs MoU with the National Forensic Sciences University to open ‘Center of Excellence’ in India

Gandhinagar, India, March 18, 2021 – Thermo Fisher Scientific, the world leader in serving science, signed an MoU with the National Forensic Science...
2 Mar, 2021
Cipla receives final approval for generic version of GlaxoSmithKline’s IMITREX® (Sumatriptan Nasal Spray, 20 mg)

Mumbai, India, March 02, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ hereinafter referred to as “Cipla”) today announced that it has received ...
25 Feb, 2021
Sun Pharma Launches Website for its Long-Term Care Portfolio in the U.S.

Mumbai, India, and Princeton, NJ, February 25, 2021 – Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, B...
18 Feb, 2021
New Thermo Fisher Scientific Manufacturing Facility in Bengaluru to Produce reliable COVID-19 Testing Kits in India for India 

Bengaluru, India, Feb 18, 2021 – A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce COVID-19 testing ...